Curaleaf Breaks Trend, Begins Hiring Due To Pandemic Demands

It appears that Curaleaf Holdings (CSE: CURA) has broken the latest trend in the cannabis sector. Rather than looking to reduce headcounts, the company announced this morning that it is looking to hire more employees after receiving essential service designation in a number of markets in which it operates.

The designation as an essential service comes amid the COVID-19, or coronavirus, pandemic as patients and recreational consumers alike rush to secure enough cannabis to keep them content through numerous state mandated lockdowns. The increase in demand as a result has caused Curaleaf to begin hiring more staff in roles across its retail, processing, and cultivation network.

Full operations for the firm remain online in the states of New York, Oregon, New Jersey, Arizona, Maine, Florida, Maryland, while the states of Massachusetts and Nevada are open for medical operations only. The company has also modified store hours to address the increased demand, as well as dedicated shopping time for senior citizens. The company is also employing increased sanitization efforts while instituting tech to allow for curbside delivery, mobile pre-ordering, express pickup and a waitlist ordering app where allowed.

The COVID-19 situation is evolving rapidly and we are responding as quickly as possible to ensure we can continue to meet the needs of our customers. We have never been more committed to providing our vital services and products and will continue to do everything we can to fulfill that mission while protecting the wellbeing of our dedicated employees. In these difficult times, we will be hiring employees and working with local organizations to provide job opportunities to those who are out of work.

Joseph Lusardi, Chief Executive Officer of Curaleaf

Curaleaf Holdings last traded at $4.48 on the CSE.

Information for this briefing was found via Sedar and Curaleaf Holdings. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.